Skip to main content
Back to KB Investment

KB Investment's Biotechnology Portfolio

Browse 10 Biotechnology companies funded by KB Investment. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
10
Total Funding in Biotechnology
$159.2M

Biotechnology Portfolio Companies (10)

Export
BiotechnologyHealth CarePharmaceutical

MediMabBio is a biotherapeutic company that focuses on the generation of novel immunotherapies for the treatment of cancer.

Seongnam, South Korea
October 2025
$17.8M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyDiabetesHealth CareMachine LearningMedical DeviceSensor

Apollon develops noninvasive continuous glucose monitoring systems.

Cambridge, United States
April 2024
$1.7M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Mito Immune Therapeutics is a drug research and development biotech company.

Seoul, South Korea
September 2023
$3.9M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalOncology

Connext is developing biological therapeutics in the field of immuno-oncology and regenerative medicine.

Daegu, South Korea
March 2026
$10.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs.

Daejeon, South Korea
July 2025
$16.2M
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMedicalPharmaceutical

Selta Square is an AI-based drug monitoring company that offers full-cycle drug monitoring solutions using AI technology.

Seoul, South Korea
January 2025
$6.4M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth DiagnosticsRobotics

LN Robotics is a technology research firm that specializes in the development of medical robots.

Hanam, South Korea
July 2024
$14.5M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

DAAN Biotherapeutics develops novel treatments for cancer patients.

Seoul, South Korea
January 2024
$17.2M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife Science

Hyku is a biotech company that develops precise covalent targeting of disease-causing proteins.

Lexington, United States
September 2023
$56.0M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyClinical TrialsMedical

IMBiologics is a biotechnology company that develops immunomodulatory antibody drugs for physiological balance.

Seongnam, South Korea
July 2023
$15.6M
Series B

Founder Contacts

19,000+ verified contacts

Explore KB Investment's Full Portfolio

View all companies funded by KB Investment across every industry and funding stage.

View Full KB Investment Portfolio